BigHat on their innovative platform blending machine learning with lab tech for next-gen antibodies

Поделиться
HTML-код
  • Опубликовано: 27 июн 2024
  • Liz Schwarzbach, Chief Business Officer at BigHat Biosciences joins Judy Shaw on #NYSEFloorTalk to discuss their innovative platform blending machine learning with lab tech for next-gen antibodies and BigHat’s strategic collaboration with J&J.

Комментарии •